Small-Cell Lung Cancer Market Size, Symptoms, Overview and Pipeline Review, H1 2016

Submitted by: Submitted by

Views: 10

Words: 883

Pages: 4

Category: Business and Industry

Date Submitted: 07/14/2016 12:42 AM

Report This Essay

Small-Cell Lung Cancer Market Size, Causes, Outlook,

Overview and Pipeline Review, H1 2016

Summary

Global Markets Direct's, 'Small-Cell Lung Cancer - Pipeline Review, H1 2016', provides an overview of the Small-Cell

Lung Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Small-Cell Lung

Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of

administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the

therapeutics, its complete research and development history and latest news and press releases. Additionally, the

report provides an overview of key players involved in therapeutic development for Small-Cell Lung Cancer and

features dormant and discontinued projects.

For More Information, Visit @ http://www.radiantinsights.com/research/small-cell-lung-cancer-pipelinereview-h1-2016

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and

nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's

proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor

presentations and featured press releases from company/university sites and industry-specific third party sources.

Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that

all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes

ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision

making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be...